awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46675575-3675B227-8B88-49C4-8F75-862B3D29D3A4
Q46675575-3675B227-8B88-49C4-8F75-862B3D29D3A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46675575-3675B227-8B88-49C4-8F75-862B3D29D3A4
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase 1 cohorts of CheckMate 143.
P2860
Q46675575-3675B227-8B88-49C4-8F75-862B3D29D3A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46675575-3675B227-8B88-49C4-8F75-862B3D29D3A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
abd26c00c5efeaa97c00f409df221aad3dc91ca3
P2860
Bevacizumab and daily temozolomide for recurrent glioblastoma.